Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of RGN1016 in Healthy Males
NCT02820155Phase 1Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jun 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules, Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of RGN1016 in hyperuricemia, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
RGN1016
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT02820155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02820155.